Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Diego, De Miguel"'
Autor:
Maria Pilar Ruiz Seco, José Ramón Paño Pardo, Christian Schoergenhofer, Christiane Dings, Thorsten Lehr, Felix Herth, Andriy Krendyukov, Carola Straub, Martin Kappler, Bernd Jilma, Harald Fricke, Julian Pardo, Diego de Miguel, Meinolf Thiemann, Michael Bergmann, Henning Walczak, Thomas Hoeger
Publikováno v:
EClinicalMedicine, Vol 77, Iss , Pp 102879- (2024)
Summary: Background: The phase 2 ASUNCTIS study assessed the efficacy and safety of asunercept, a fully human CD95 (Fas) ligand-binding protein, in hospitalised patients with moderate-to-severe coronavirus disease (COVID-19) to assess the clinical be
Externí odkaz:
https://doaj.org/article/f34a85026187404385bbd167989aeaf9
Autor:
Erick F. Saldanha, Eleonora Nicolo, Konstantinos Venetis, Diego de Miguel-Perez, Ana Ortega-Franco, Angelo Dipasquale, Mohamed A. Gouda, Surbhi Singhal, George Adigbli, Carolina Reduzzi
Publikováno v:
The Journal of Liquid Biopsy, Vol 5, Iss , Pp 100156- (2024)
Externí odkaz:
https://doaj.org/article/5b699f2ae6014e98a8ae5423223dc0a9
Autor:
Diego de Miguel‑Perez, Murat Ak, Priyadarshini Mamindla, Alessandro Russo, Serafettin Zenkin, Nursima Ak, Vishal Peddagangireddy, Luis Lara‑Mejia, Muthukumar Gunasekaran, Andres F. Cardona, Aung Naing, Fred R. Hirsch, Oscar Arrieta, Rivka R. Colen, Christian Rolfo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-6 (2024)
Abstract Background Immune-checkpoint inhibitors (ICIs) have showed unprecedent efficacy in the treatment of patients with advanced non-small cell lung cancer (NSCLC). However, not all patients manifest clinical benefit due to the lack of reliable pr
Externí odkaz:
https://doaj.org/article/aef1eb16e7a04127b7be386a1b11b7d4
Autor:
Diego de Miguel-Perez, Francisco Gabriel Ortega, Rosario Guerrero Tejada, Antonio Martínez-Única, Christine B. Peterson, Alessandro Russo, Muthukumar Gunasekaran, Andres F. Cardona, Victor Amezcua, Jose Antonio Lorente, Jose Expósito Hernández, Christian Rolfo, Maria Jose Serrano
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-5 (2023)
Abstract Concurrent chemoradiotherapy (cCRT) is the mainstay of treatment for patients diagnosed with locally advanced non-small cell lung cancer (NSCLC). One significant challenge in the effectiveness of this therapy is the potential development of
Externí odkaz:
https://doaj.org/article/54cef4701eaf47f1b498e777f8744fa9
Autor:
Del Re, Marzia, Luculli, Giovanna Irene, Petrini, Iacopo, Sbrana, Andrea, Scotti, Vieri, Perez, Diego de Miguel, Livi, Lorenzo, Crucitta, Stefania, Iannopollo, Mauro, Mazzoni, Francesca, Ruglioni, Martina, Tibaldi, Carmelo, Olmetto, Emanuela, Stasi, Irene, Baldini, Editta, Allegrini, Giacomo, Antonuzzo, Lorenzo, Morelli, Franco, Pierini, Andrea, Panzeri, Nicola, Fogli, Stefano, Chella, Antonio, Rolfo, Christian, Danesi, Romano
Publikováno v:
In Translational Oncology March 2024 41
Autor:
Marzia Del Re, Giovanna Irene Luculli, Iacopo Petrini, Andrea Sbrana, Vieri Scotti, Diego de Miguel Perez, Lorenzo Livi, Stefania Crucitta, Mauro Iannopollo, Francesca Mazzoni, Martina Ruglioni, Carmelo Tibaldi, Emanuela Olmetto, Irene Stasi, Editta Baldini, Giacomo Allegrini, Lorenzo Antonuzzo, Franco Morelli, Andrea Pierini, Nicola Panzeri, Stefano Fogli, Antonio Chella, Christian Rolfo, Romano Danesi
Publikováno v:
Translational Oncology, Vol 41, Iss , Pp 101869- (2024)
Background: The present study evaluates the utility of NGS analysis of circulating free DNA (cfDNA), which incorporates small amounts of tumor DNA (ctDNA), at diagnosis or at disease progression (PD) in NSCLC patients. Methods: Comprehensive genomic
Externí odkaz:
https://doaj.org/article/262397be030b4702b3e34b61b234daba
Autor:
Valeria Denninghoff, María del Carmen Garrido-Navas, María del Pilar Molina-Vallejo, Abel García-Díaz, José Miguel Pérez-Villares, Manuel Colmenero-Ruiz, José Expósito-Hernández, Jose Antonio Lorente, José María Navarro-María, Juan José Díaz-Mochón, Diego de Miguel-Perez, Christian Rolfo, Pedro José Romero-Palacios, Bernardino Alcázar Navarrete, María José Serrano
Publikováno v:
The Journal of Liquid Biopsy, Vol 2, Iss , Pp 100005- (2023)
Liquid biopsy (LB) is a minimally invasive procedure that detects biomarkers in body fluids for real-time monitoring of patients. This study developed a new LB approach to analyze Circulating Epithelial Cells (CECs) in Intensive Care Unit (ICU) patie
Externí odkaz:
https://doaj.org/article/2ecadba8db984f33ac418d327c16ceaf
Autor:
Cardona, Andrés F., Ruiz-Patiño, Alejandro, Recondo, Gonzalo, Martín, Claudio, Raez, Luis, Samtani, Suraj, Minatta, José Nicolas, Blaquier, Juan Bautista, Enrico, Diego, Burotto, Mauricio, Ordóñez-Reyes, Camila, Chamorro, Diego F., Garcia-Robledo, Juan Esteban, Corrales, Luis, Zatarain-Barrón, Zyanya Lucia, Más, Luis, Sotelo, Carolina, Ricaurte, Luisa, Santoyo, Nicolas, Cuello, Mauricio, Mejía, Sergio, Jaller, Elvira, Vargas, Carlos, Carranza, Hernán, Otero, Jorge, Rodríguez, July, Archila, Pilar, Bermudez, Maritza, Gamez, Tatiana, Cordeiro de Lima, Vladmir, Freitas, Helano, Russo, Alessandro, Polo, Carolina, Malapelle, Umberto, Perez, Diego de Miguel, Rolfo, Christian, Viola, Lucia, Rosell, Rafael, Arrieta, Oscar
Publikováno v:
In Clinical Lung Cancer September 2022 23(6):522-531
Autor:
Diego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, Murat Ak, Feliciano Barron, Muthukumar Gunasekaran, Priyadarshini Mamindla, Luis Lara-Mejia, Christine B. Peterson, Mehmet E. Er, Vishal Peddagangireddy, Francesco Buemi, Brandon Cooper, Paolo Manca, Rena G. Lapidus, Ru-Ching Hsia, Andres F. Cardona, Aung Naing, Sunjay Kaushal, Fred R. Hirsch, Philip C. Mack, Maria Jose Serrano, Vincenzo Adamo, Rivka R. Colen, Christian Rolfo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-14 (2022)
Abstract Background Immune-checkpoint inhibitors (ICIs) changed the therapeutic landscape of patients with lung cancer. However, only a subset of them derived clinical benefit and evidenced the need to identify reliable predictive biomarkers. Liquid
Externí odkaz:
https://doaj.org/article/4c65ef22566e4f538c868b2b0b00c400
Autor:
Norma Hernández-Pedro, Marisol Arroyo-Hernández, Pedro Barrios-Bernal, Eunice Romero-Nuñez, Victor A. Sosa-Hernandez, Santiago Ávila-Ríos, José Luis Maravillas-Montero, Rogelio Pérez-Padilla, Diego de Miguel-Perez, Christian Rolfo, Oscar Arrieta
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1612 (2023)
Immune dysregulation and cancer treatment may affect SARS-CoV-2 vaccination protection. Antibody production by B-cells play a vital role in the control and clearance of the SARS-CoV-2 virus. This study prospectively explores B-cell seroconversion fol
Externí odkaz:
https://doaj.org/article/3302dca92f0740a4b751982bbd6c32ba